Literature DB >> 825470

Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.

M Pollack, L T Callahan, N S Taylor.   

Abstract

Antibody to Pseudomonas aeruginosa exotoxin was detected in human sera by using a cytotoxicity-neutralization assay. Serum antitoxin was present in high titer in all 14 patients who recovered from serious pseudomonas infections (log2 of 50% neutralization titer, mean +/- standard deviation = 6.0 +/- 1.2). In contrast, serum antitoxin was present in lower titer in four of seven patients with fatal pseudomonas infections (3.3 +/- 2.7, P less than 0.005), in 3 of 7 patients with non-pseudomonas infections (1.4 +/- 0.6 P less than 0.001), and in 6 of 14 normal control subjects (2.0 +/- 1.3, P less than 0.001). Fourfold or greater serum antitoxin rises were demonstrated in two survivors of acute infections, and toxin-neutralizing activity was associated with the immunoglobulin G fraction of human sera. Immunization of rabbits with purified exotoxin also induced high antitoxin titers.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 825470      PMCID: PMC415475          DOI: 10.1128/iai.14.4.942-947.1976

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  NAD-dependent inhibition of protein synthesis by Pseudomonas aeruginosa toxin,.

Authors:  B H Iglewski; D Kabat
Journal:  Proc Natl Acad Sci U S A       Date:  1975-06       Impact factor: 11.205

2.  Purification and characterization of Pseudomonas aeruginosa exotoxin.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1974-01       Impact factor: 3.441

3.  Comparative studies on Pseudomonas aeruginosa endotoxin.

Authors:  J W Dyke; R S Berk
Journal:  Z Allg Mikrobiol       Date:  1973

4.  Use of microculture plates and the multiple automated sample harvester for in vitro microassay of bacterial toxins.

Authors:  R C Knudsen; L T Callahan; A Ahmed; K W Sell
Journal:  Appl Microbiol       Date:  1974-08

5.  Pseudomonas aeruginosa in a center for cancer research. I. Distribution of intraspecies types from human and environmental sources.

Authors:  M R Moody; V M Young; D M Kenton; G D Vermeulen
Journal:  J Infect Dis       Date:  1972-02       Impact factor: 5.226

6.  Pseudomonas aeruginosa exotoxin: effect on cell cultures.

Authors:  O R Pavlovskis; F B Gordon
Journal:  J Infect Dis       Date:  1972-06       Impact factor: 5.226

7.  In vivo studies with collagenase from Pseudomonas aeruginosa.

Authors:  B Diener; L Carrick; R S Berk
Journal:  Infect Immun       Date:  1973-02       Impact factor: 3.441

8.  Pseudomonas aeruginosa exotoxin: purification by preparative polyacrylamide gel electrophoresis and the development of a highly specific antitoxin serum.

Authors:  L T Callahan
Journal:  Infect Immun       Date:  1976-07       Impact factor: 3.441

9.  In vivo studies on protease and elastase from Pseudomonas aeruginosa.

Authors:  K Kawaharajo; J Y Homma; Y Aoyama; K Morihara
Journal:  Jpn J Exp Med       Date:  1975-04

10.  Pseudomonas aeruginosa exotoxin in mice: localization and effect on protein synthesis.

Authors:  O R Pavlovskis; A H Shackelford
Journal:  Infect Immun       Date:  1974-03       Impact factor: 3.441

View more
  38 in total

1.  Purification of Pseudomonas aeruginosa exotoxin by affinity chromatography.

Authors:  N S Taylor; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

2.  Effect of iron on yields of exotoxin A in cultures of Pseudomonas aeruginosa PA-103.

Authors:  M J Bjorn; B H Iglewski; S K Ives; J C Sadoff; M L Vasil
Journal:  Infect Immun       Date:  1978-03       Impact factor: 3.441

3.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

4.  Detection of anti-Vibrio vulnificus cytolysin antibodies in sera from mice and a human surviving V. vulnificus disease.

Authors:  L D Gray; A S Kreger
Journal:  Infect Immun       Date:  1986-03       Impact factor: 3.441

5.  Microscopic characterization of ocular damage produced by Pseudomonas aeruginosa toxin A.

Authors:  L D Hazlett; R S Berk; B H Iglewski
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

6.  Mechanism of action of Pseudomonas aeruginosa exotoxin A in experimental mouse infections: adenosine diphosphate ribosylation of elongation factor 2.

Authors:  O R Pavlovskis; B H Iglewski; M Pollack
Journal:  Infect Immun       Date:  1978-01       Impact factor: 3.441

7.  Serum antibody to Pseudomonas aeruginosa exotoxin measured by a passive hemagglutination assay.

Authors:  M Pollack; N S Taylor
Journal:  J Clin Microbiol       Date:  1977-07       Impact factor: 5.948

8.  Antibodies to cell envelope proteins of Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  P B Fernandes; C Kim; K R Cundy; N N Haung
Journal:  Infect Immun       Date:  1981-08       Impact factor: 3.441

9.  Fms-like tyrosine kinase-3 ligand alters antigen-specific responses to infections after severe burn injury.

Authors:  Julia Bohannon; Geping Fang; Weihua Cui; Edward Sherwood; Tracy Toliver-Kinsky
Journal:  Shock       Date:  2009-10       Impact factor: 3.454

10.  Active immunization using exotoxin A confers protection against Pseudomonas aeruginosa infection in a mouse burn model.

Authors:  Ali Manafi; Jamshid Kohanteb; Davood Mehrabani; Aziz Japoni; Masoud Amini; Mohsen Naghmachi; Ahmad Hosseinzadeh Zaghi; Nazanin Khalili
Journal:  BMC Microbiol       Date:  2009-02-01       Impact factor: 4.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.